Table 8 Top 20 cited articles on vaccine – related publication on studied diseases
From: Global research trends of World Health Organization’s top eight emerging pathogens
Title | Year | Journal | Number of citations |
|---|---|---|---|
Development of a preventive vaccine for Ebola virus infection in primates [111] | 2000 | Nature | 490 |
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates [112] | 2003 | Nature | 336 |
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses [113] | 2005 | Nature Medicine | 320 |
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice [114] | 2004 | Nature | 320 |
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice [115] | 2004 | PNAS | 232 |
Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates [116] | 1998 | Virology | 199 |
Effects of a SARS-associated coronavirus vaccine in monkeys [117] | 2003 | Lancet | 168 |
Ebola virus: From discovery to vaccine [118] | 2003 | Nature Reviews Immunology | 168 |
Evaluation in nonhuman primates of vaccines against Ebola virus [119] | 2002 | Emerging Infectious Diseases | 166 |
Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus [120] | 2003 | Avian Pathology | 152 |
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge [121] | 2007 | Journal of Infectious Diseases | 149 |
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial [122] | 2015 | The Lancet | 137 |
DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge [123] | 1998 | Virology | 136 |
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial [124] | 2006 | Clinical and Vaccine Immunology | 134 |
Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus [125] | 2009 | Journal of Virology | 127 |
Development of a new vaccine for the prevention of Lassa fever [126] | 2005 | PLoS Medicine | 115 |
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: Implication for developing subunit vaccine [127] | 2004 | Biochemical and Biophysical Research Communications | 115 |
Correlates of protective immunity for Ebola vaccines: Implications for regulatory approval by the animal rule [128] | 2009 | Nature Reviews Microbiology | 105 |
Nipah Virus: Vaccination and Passive Protection Studies in a Hamster Model [129] | 2004 | Journal of Virology | 105 |
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region [130] | 2005 | Journal of Virology | 101 |